Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2025 Earnings Call Transcript February 24, 2026
Operator: Good afternoon, and welcome to Vir Biotechnology’s conference call to discuss the company’s VIR-5500 Strategic Collaboration with Astellas and Positive Phase I Data, and 2025 financial results. As a reminder, this conference call is being recorded. [Operator Instructions] I will now turn the call over to Kiki Patel, Head of Investor Relations. You may begin, Kiki.
Kiki Patel: Thank you,...
